Related Experiment Video
Updated: Apr 11, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Circadian Dependence of Infarct Size and Acute Heart Failure in ST Elevation Myocardial Infarction
Aruni Seneviratna1, Gek Hsiang Lim2, Anju Devi2
1Cardiac Department, National University Heart Centre, National University Hospital, Singapore, Singapore.
Insights
ST-elevation myocardial infarction (STEMI) infarct size and acute heart failure risk show a circadian pattern. Symptoms starting midnight to 6 AM are linked to larger infarcts and worse outcomes, while 6 AM to noon onset shows the opposite.
Area of Science:
- Cardiology
- Circadian Biology
- Biomedical Science
Background:
- Conflicting data exists on circadian influence on ST-elevation myocardial infarction (STEMI) infarct size.
- The impact of circadian patterns on STEMI clinical outcomes remains largely unknown.
Purpose of the Study:
- To investigate the circadian dependence of infarct size in STEMI.
- To determine the impact of infarct size circadian patterns on clinical outcomes.
Main Methods:
- A study of 6,710 STEMI patients hospitalized between 2006-2009.
- Symptom onset categorized into four 6-hour intervals.
- Peak creatine kinase used as a surrogate marker for infarct size.
Main Results:
- Patients with symptom onset from midnight to 6 AM had the largest infarct size (peak creatine kinase) and highest risk of acute heart failure and mortality.
- Patients with onset from 6 AM to noon showed the smallest infarct size and lowest risk.
- Circadian variations in acute heart failure incidence remained significant after adjusting for key clinical factors.
Conclusions:
- A circadian pattern in infarct size and acute heart failure incidence was observed in STEMI.
- Onset from midnight to 6 AM is associated with peak infarct size and adverse outcomes.
- Differences in diabetes, infarct location, and reperfusion therapy may partly explain these circadian variations.
Objectives:
There are conflicting data on the relationship between the time of symptom onset during the 24-hour cycle (circadian dependence) and infarct size in ST-elevation myocardial infarction (STEMI). Moreover, the impact of this circadian pattern of infarct size on clinical outcomes is unknown. We sought to study the circadian dependence of infarct size and its impact on clinical outcomes in STEMI.
Methods:
We studied 6,710 consecutive patients hospitalized for STEMI from 2006 to 2009 in a tropical climate with non-varying day-night cycles. We categorized the time of symptom onset into four 6-hour intervals: midnight-6:00 A.M., 6:00 A.M.-noon, noon-6:00 P.M. and 6:00 P.M.-midnight. We used peak creatine kinase as a surrogate marker of infarct size.
Results:
Midnight-6:00 A.M patients had the highest prevalence of diabetes mellitus (P = 0.03), more commonly presented with anterior MI (P = 0.03) and received percutaneous coronary intervention less frequently, as compared with other time intervals (P = 0.03). Adjusted mean peak creatine kinase was highest among midnight-6:00 A.M. patients and lowest among 6:00 A.M.-noon patients (2,590.8±2,839.1 IU/L and 2,336.3±2,386.6 IU/L, respectively, P = 0.04). Midnight-6:00 A.M patients were at greatest risk of acute heart failure (P<0.001), 30-day mortality (P = 0.03) and 1-year mortality (P = 0.03), while the converse was observed in 6:00 A.M.-noon patients. After adjusting for diabetes, infarct location and performance of percutaneous coronary intervention, circadian variations in acute heart failure incidence remained strongly significant (P = 0.001).
Conclusion:
We observed a circadian peak and nadir in infarct size during STEMI onset from midnight-6:00A.M and 6:00A.M.-noon respectively. The peak and nadir incidence of acute heart failure paralleled this circadian pattern. Differences in diabetes prevalence, infarct location and mechanical reperfusion may account partly for the observed circadian pattern of infarct size and acute heart failure.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

